Publications by authors named "Ann Moormann"

The WHO recommends hepatitis B birth-dose vaccination (HepB-BD), but it is not routinely given in most sub-Saharan African countries. We aimed to assess the immunogenicity of HepB-BD in addition to the existing hepatitis B vaccine (HepB3) schedule in Kinshasa, Democratic Republic of Congo among HBV-unexposed and HBV-exposed infants. Using an open-label, randomised, controlled design, HBV-unexposed infants were randomised (1:1) to receive the standard HepB3 vaccine series (group U3), or to receive HepB-BD in addition to HepB3 (group U4).

View Article and Find Full Text PDF
Article Synopsis
  • COVID-19 had a significant impact on minority communities, highlighting the need for better research engagement with these groups, while existing evaluation methods hinder comprehensive analysis.
  • A cross-sectional study in Massachusetts showed that 91.4% of 290 participants had received a COVID-19 vaccine, and 41.7% reported past infections, with findings indicating varying antibody responses and lingering symptoms, particularly among middle-aged Latinas.
  • The study emphasized the importance of using saliva samples for serology and introduced standardized methods for better future evaluations, enhancing the understanding of COVID-19 and public health responses in underserved populations.
View Article and Find Full Text PDF

Background: The Zanzibar archipelago of Tanzania has become a low-transmission area for . Despite being considered an area of pre-elimination for years, achieving elimination has been difficult, likely due to a combination of imported infections from mainland Tanzania and continued local transmission.

Methods: To shed light on these sources of transmission, we applied highly multiplexed genotyping utilizing molecular inversion probes to characterize the genetic relatedness of 282 isolates collected across Zanzibar and in Bagamoyo district on the coastal mainland from 2016 to 2018.

View Article and Find Full Text PDF

COVID-19 disproportionately affected minorities, while research barriers to engage underserved communities persist. Serological studies reveal infection and vaccination histories within these communities, however lack of consensus on downstream evaluation methods impede meta-analyses and dampen the broader public health impact. To reveal the impact of COVID-19 and vaccine uptake among diverse communities and to develop rigorous serological downstream evaluation methods, we engaged racial and ethnic minorities in Massachusetts in a cross-sectional study (April - July 2022), screened blood and saliva for SARS-CoV-2 and human endemic coronavirus (hCoV) antibodies by bead-based multiplex assay and point-of-care (POC) test and developed across-plate normalization and classification boundary methods for optimal qualitative serological assessments.

View Article and Find Full Text PDF

Background: Circulating T-follicular helper (cT ) cells have the potential to provide an additional correlate of protection against ( as they are essential to promote B cell production of long-lasting antibodies. Assessing the specificity of cT subsets to individual malaria antigens is vital to understanding the variation observed in antibody responses and identifying promising malaria vaccine candidates.

Methods: Using spectral flow cytometry and unbiased clustering analysis we assessed antigen-specific cT cell recall responses to malaria vaccine candidates SEA-1A and GARP within a cross-section of children and adults living in a malaria holoendemic region of western Kenya.

View Article and Find Full Text PDF

Epstein-Barr virus (EBV) infects over 95% of adults worldwide. Given its connection to various cancers and autoimmune disorders, it is important to understand the mechanisms by which infection with EBV can lead to these diseases. In this study, we describe an unusual spontaneous lytic phenotype in EBV strains isolated from Kenyan endemic Burkitt lymphoma patients.

View Article and Find Full Text PDF

Endemic Burkitt lymphoma (eBL) is a fast-growing germinal center B cell lymphoma, affecting 5-10 per 100,000 children annually, in the equatorial belt of Africa. We hypothesize that co-infections with Plasmodium falciparum (Pf) malaria and Epstein-Barr virus (EBV) impair host natural killer (NK) and T cell responses to tumor cells, and thus increase the risk of eBL pathogenesis. NK cell education is partially controlled by killer immunoglobulin-like receptors and variable expression of KIR3DL1 has been associated with other malignancies.

View Article and Find Full Text PDF

SARS-CoV-2-positive patients exhibit gut and oral microbiome dysbiosis, which is associated with various aspects of COVID-19 disease (1-4). Here, we aim to identify gut and oral microbiome markers that predict COVID-19 severity in hospitalized patients, specifically severely ill patients compared to moderately ill ones. Moreover, we investigate whether hospital feeding (solid versus enteral), an important cofounder, influences the microbial composition of hospitalized COVID-19 patients.

View Article and Find Full Text PDF

Background: Infants receive their first bacteria from their birthing parent. This newly acquired microbiome plays a pivotal role in developing a robust immune system, the cornerstone of long-term health.

Results: We demonstrated that the gut, vaginal, and oral microbial diversity of pregnant women with SARS-CoV-2 infection is reduced, and women with early infections exhibit a different vaginal microbiota composition at the time of delivery compared to their healthy control counterparts.

View Article and Find Full Text PDF

Background: Indiana University (IU) initiated fluorescence in situ hybridisation (FISH) methodology for Burkitt Lymphoma (BL) to advance the accuracy and speed of diagnosis in the AMPATH Reference Laboratory at Moi Teaching and Referral Hospital (MTRH) in Eldoret, Kenya. Standard diagnostic testing for BL at MTRH includes morphology of the biopsy specimen or aspirate and limited immunohistochemistry panels.

Methods: Tumour specimens from 19 children enrolled from 2016 to 2018 in a prospective study to improve the diagnosis and staging of children with suspected BL were evaluated.

View Article and Find Full Text PDF

The seroprevalence of Kaposi sarcoma-associated herpesvirus (KSHV) and the incidence of endemic Kaposi sarcoma (KS) overlap with regions of malaria endemicity in sub-Saharan Africa. Multiple studies have shown an increased risk of KSHV seroconversion in children from high malaria compared to low malaria regions; however, the impact of acute episodes of () malaria on KSHV's biphasic life cycle and lytic reactivation has not been determined. Here, we examined KSHV serological profiles and viral loads in 134 children with acute malaria and 221 healthy children from high malaria regions in Kisumu, as well as 77 healthy children from low malaria regions in Nandi.

View Article and Find Full Text PDF

Endemic Burkitt lymphoma (BL) is a childhood cancer in sub-Saharan Africa characterized by Epstein-Barr virus and malaria-associated aberrant B-cell activation and chromosomal translocation. Survival rates hover at 50% after conventional chemotherapies; therefore, clinically relevant models are necessary to test additional therapies. Hence, we established five patient-derived BL tumor cell lines and corresponding NSG-BL avatar mouse models.

View Article and Find Full Text PDF

The Zanzibar archipelago of Tanzania has become a low-transmission area for Despite being considered an area of pre-elimination for years, achieving elimination has been difficult, likely due to a combination of imported infections from mainland Tanzania, and continued local transmission. To shed light on these sources of transmission, we applied highly multiplexed genotyping utilizing molecular inversion probes to characterize the genetic relatedness of 282 isolates collected across Zanzibar and in Bagamoyo District on the coastal mainland from 2016-2018. Overall, parasite populations on the coastal mainland and Zanzibar archipelago remain highly related.

View Article and Find Full Text PDF
Article Synopsis
  • The objective of the study was to investigate the demographic differences between pregnant individuals with COVID-19 who agreed to participate in research versus those who declined, focusing on the impact of SARS-CoV-2 on maternal health outcomes, especially in minority and low-income populations.
  • The methods included a secondary analysis of demographic data from a single hospital, utilizing electronic medical records and Chi-square testing to compare characteristics like race, ethnicity, primary language, and insurance type among those who participated and those who did not.
  • The results showed that out of 158 approached pregnant patients with COVID-19, 89 consented to participate while 69 declined, indicating a need to address disparities in research participation among different demographic groups.
View Article and Find Full Text PDF

Background: Endemic Burkitt lymphoma (eBL) is potentiated through the interplay of Epstein Barr virus (EBV) and holoendemic Plasmodium falciparum malaria. To better understand EBV's biology and role in eBL, we characterized genome-wide recombination sites and patterns as a source of genetic diversity in EBV genomes in our well-defined population of eBL cases and controls from Western Kenya.

Methods: EBV genomes representing 54 eBL cases and 32 healthy children from the same geographic region in Western Kenya that we previously sequenced were analyzed.

View Article and Find Full Text PDF

Background: Evaluating the performance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serological assays and clearly articulating the utility of selected antigens, isotypes, and thresholds is crucial to understanding the prevalence of infection within selected communities.

Methods: This cross-sectional study, implemented in 2020, screened PCRconfirmed coronavirus disease 2019 patients (n 86), banked prepandemic and negative samples (n 96), healthcare workers and family members (n 552), and university employees (n 327) for antiSARS-CoV-2 receptor-binding domain, trimeric spike protein, and nucleocapsid protein immunoglobulin (Ig)G and IgA antibodies with a laboratory-developed enzyme-linked immunosorbent assay and tested how antigen, isotype and threshold choices affected the seroprevalence outcomes. The following threshold methods were evaluated: (i) mean 3 standard deviations of the negative controls; (ii) 100 specificity for each antigen-isotype combination; and (iii) the maximal Youden index.

View Article and Find Full Text PDF

A disproportionate burden of the ongoing COVID-19 pandemic is being shouldered by members of racial and ethnic minorities and socially disadvantaged communities. Structural and social determinants of health have been recognized as key contributors to the inequalities observed. Racism, a major structural determinant of health that patterns related social determinants of health, in the USA, warrants further investigation.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how the oropharyngeal microbiome, which is the community of microorganisms in the upper respiratory tract, affects the severity of COVID-19 in patients presenting with acute symptoms.
  • Among 115 patients tested for COVID-19, 50 had confirmed positive results; of these, 76% required supplemental oxygen support.
  • Machine learning methods revealed that certain low-abundance microorganisms and metabolic pathways in the microbiome can predict the need for respiratory support in COVID-19 patients.
View Article and Find Full Text PDF

Background: Global efforts are needed to elucidate the epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the underlying cause of coronavirus disease 2019 (COVID-19), including seroprevalence, risk factors, and long-term sequelae, as well as immune responses after vaccination across populations and the social dimensions of prevention and treatment strategies.

Methods: In the United States, the National Cancer Institute in partnership with the National Institute of Allergy and Infectious Diseases, established the SARS-CoV-2 Serological Sciences Network (SeroNet) as the nation's largest coordinated effort to study coronavirus disease 2019. The network comprises multidisciplinary researchers bridging gaps and fostering collaborations among immunologists, epidemiologists, virologists, clinicians and clinical laboratories, social and behavioral scientists, policymakers, data scientists, and community members.

View Article and Find Full Text PDF
Article Synopsis
  • The National Cancer Institute established the Serological Sciences Network (SeroNet) in October 2020 to study immune responses to COVID-19 and enhance serological testing technologies.
  • SeroNet involves 25 research institutions collaborating on COVID-19 serological assays, including developing and sharing assay procedures and harmonization plans.
  • A structured approach was taken to calibrate various serological assays to reference standards, resulting in a wide range of developed assays that will allow for consistent reporting and future data comparisons across studies.
View Article and Find Full Text PDF

Sequence homology between SARS-CoV-2 and common-cold human coronaviruses (HCoVs) raises the possibility that memory responses to prior HCoV infection can affect T cell response in COVID-19. We studied T cell responses to SARS-CoV-2 and HCoVs in convalescent COVID-19 donors and identified a highly conserved SARS-CoV-2 sequence, S, with overlapping epitopes presented by common MHC class II proteins HLA-DQ5 and HLA-DP4. These epitopes are recognized by low-abundance CD4 T cells from convalescent COVID-19 donors, mRNA vaccine recipients, and uninfected donors.

View Article and Find Full Text PDF

Background: resistance to artemisinin-based combination therapies (ACTs) is a threat to malaria elimination. ACT-resistance in Asia raises concerns for emergence of resistance in Africa. While most data show high efficacy of ACT regimens in Africa, there have been reports describing declining efficacy, as measured by both clinical failure and prolonged parasite clearance times.

View Article and Find Full Text PDF

The resurgence of drug-resistant Plasmodium falciparum parasites continues to motivate the development of a safe and efficacious malaria vaccine. Immuno-epidemiologic studies of naturally acquired immunity (NAI) have been a useful strategy to identify new malaria vaccine targets. However, retention of pediatric participants throughout longitudinal studies is essential for gathering comprehensive exposure and outcome data.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates how the oropharyngeal microbiome might influence the severity of COVID-19 in patients presenting with acute symptoms.
  • * Out of 115 patients, 74 tested positive for COVID-19, with a significant percentage (76%) requiring respiratory support.
  • * The analysis identified certain microbial characteristics and metabolic pathways that could predict the need for respiratory interventions, indicating that the microbiome may impact the progression of severe COVID-19 symptoms.*
View Article and Find Full Text PDF
Article Synopsis
  • - In October 2020, the National Cancer Institute launched the Serological Sciences Network (SeroNet) to research the immune response to COVID-19 and improve serological testing through collaboration among 25 research institutions.
  • - A detailed survey was conducted to gather information on various COVID-19 serological assays, while a protocol was established to calibrate these assays to reference standards for better data comparison.
  • - SeroNet institutions developed multiple COVID-19 serological assay methods and standardized calibration protocols, which will enhance the accuracy and comparability of future studies on SARS-CoV-2 and vaccine responses.
View Article and Find Full Text PDF